(Q45258847)

11 December 2017

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients (English)

1 reference

11 December 2017

1 reference

1 reference

1 reference

Sadahiro Abe

1

1 reference

11 December 2017

Koji Chiba

2

1 reference

11 December 2017

Brenda Cirincione

3

1 reference

11 December 2017

Thaddeus H Grasela

4

1 reference

11 December 2017

Kaori Ito

5

1 reference

11 December 2017

Toshio Suwa

6

1 reference

11 December 2017

language of work or name

1 reference

23 June 2009

1 reference

The Journal of Clinical Pharmacology

11 December 2017

1 reference

11 December 2017

49

1 reference

11 December 2017

9

1 reference

11 December 2017

1071-1078

1 reference

Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.

11 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

A multicenter evaluation of linezolid antimicrobial activity in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Linezolid absolute bioavailability and the effect of food on oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Initial empirical antimicrobial therapy: duration and subsequent modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Stability and performance of a population pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Linezolid: a review of its use in the management of serious gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Age and sex effects on the pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetic-pharmacodynamic crisis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

Pharmacokinetics of linezolid in subjects with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009337947

21 January 2018

Identifiers

DOI

10.1177/0091270009337947

1 reference

11 December 2017

1 reference